Children's Oncology Group's 2013 blueprint for research: stem cell transplantation.
Children's Oncology Group's 2013 blueprint for research: stem cell transplantation.
复制标题
DOI：
10.1002/pbc.24437
复制
发表时间：
2013-06
影响因子：
3.2
通讯作者：
Pulsipher, Michael A.
中科院分区：
文献类型：
--
作者：
Grupp, Stephan A.;Dvorak, Christopher C.;Nieder, Michael L.;Levine, John E.;Wall, Donna A.;Langholz, Bryan;Pulsipher, Michael A.
The role of SCT in pediatric oncology has continued to evolve with the introduction of new therapeutic agents and immunological insights into cancer. COG has focused its efforts on the study of hematopoietic stem cell transplantation in the treatment of pediatric malignancies in several major multi-institutional Phase II and Phase III studies. These studies include addressing the impact of allogenicity in ALL (ASCT0431), and establishing autologous stem cell transplant as the standard of care in neuroblastoma. Reducing transplant- associated toxicity was addressed in the ASCT0521 study, where the TNFα inhibitor etanercept was tested for the treatment of idiopathic pneumonia syndrome. Impact of cell dose was explored in the single versus tandem umbilical cord blood study CTN-0501, in close collaboration with the BMT-CTN. Pediatr Blood Cancer 2013;60:1044–1047.
登录
查看更多内容
影响因子：
20.3
作者：
Locatelli, F;Nöllke, P;Niemeyer, CM
通讯作者：
Niemeyer, CM
影响因子：
20.3
作者：
Frangoul, Haydar;Nemecek, Eneida R.;Grupp, Stephan A.
通讯作者：
Grupp, Stephan A.
DOI：
10.1053/bbmt.2002.v8.pm12171486
发表时间：
2002-01-01
影响因子：
4.3
作者：
Yanik, G;Hellerstedt, B;Cooke, KR
通讯作者：
Cooke, KR
带有嵌合抗原受体的T细胞具有有效的抗肿瘤作用，可以在晚期白血病患者中建立记忆。
影响因子：
17.1
作者：
Kalos M;Levine BL;Porter DL;Katz S;Grupp SA;Bagg A;June CH
通讯作者：
June CH
影响因子：
4.3
作者：
Uberti, JP;Ayash, L;Levine, JE
通讯作者：
Levine, JE